| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2012.02.038 |
| P698 | PubMed publication ID | 22381074 |
| P2093 | author name string | Salvador F Ausar | |
| Annie Dookie | |||
| Kevin Harper | |||
| Belma Ljutic | |||
| Marin Ming | |||
| Martina Ochs | |||
| Benjamin Messham | |||
| P2860 | cites work | Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response | Q82910116 |
| Preformulation studies--The next advance in aluminum adjuvant-containing vaccines | Q84269723 | ||
| Aluminum salts in vaccines--US perspective | Q28218439 | ||
| Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants | Q29615635 | ||
| Rapid pneumococcal evolution in response to clinical interventions | Q29616646 | ||
| Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines | Q33673241 | ||
| Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence | Q33886611 | ||
| Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines | Q33933255 | ||
| Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis | Q34005995 | ||
| Mechanisms of stimulation of the immune response by aluminum adjuvants | Q34787679 | ||
| Pneumococcal Vaccination and Revaccination of Older Adults | Q34926870 | ||
| Overcharging in colloids: beyond the Poisson-Boltzmann approach. | Q35098371 | ||
| Towards an understanding of the adjuvant action of aluminium | Q35138579 | ||
| Vaccine Adjuvants: Putting Innate Immunity to Work | Q36168232 | ||
| Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies | Q36558990 | ||
| Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation | Q36968256 | ||
| Serotype-specific problems associated with pneumococcal conjugate vaccination | Q37071137 | ||
| Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae | Q37111830 | ||
| A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae | Q37333825 | ||
| Mechanism of action of clinically approved adjuvants | Q37402088 | ||
| Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®]. | Q37794965 | ||
| Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. | Q37910264 | ||
| Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis | Q39023214 | ||
| Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity | Q39576961 | ||
| Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups | Q40166521 | ||
| Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal disease | Q42708867 | ||
| Aluminum compounds used as adjuvants in vaccines | Q43747182 | ||
| Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen | Q44788256 | ||
| Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine | Q45122273 | ||
| Measuring the surface area of aluminum hydroxide adjuvant. | Q52413573 | ||
| The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. | Q53854379 | ||
| The Influence of Various Adjuvants on the Metabolism of Phospholipids in Macrophages | Q59410967 | ||
| Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005 | Q59538885 | ||
| Antibody response to pneumococcal vaccination in children younger than five years of age | Q71831864 | ||
| [Principal comments on active vaccination against poliomyelitis.] | Q78582156 | ||
| P433 | issue | 19 | |
| P304 | page(s) | 2981-2988 | |
| P577 | publication date | 2012-02-27 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants | |
| P478 | volume | 30 |
| Q89734659 | Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation |
| Q42272103 | Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice |
| Q38721098 | Biophysical Characterization and Thermal Stability of Pneumococcal Histidine Triad Protein D in the Presence of Zinc and Manganese |
| Q34637890 | Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives |
| Q35531214 | Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children |
| Q34057765 | Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge |
| Q34866385 | Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker. |
| Q90564961 | Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens |
| Q52365761 | Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1. |
| Q42036323 | Mechanism of immunopotentiation and safety of aluminum adjuvants. |
| Q37174555 | Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms |
| Q57478910 | Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want |
| Q37264979 | Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis |
| Q89969392 | Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant |
| Q104105760 | Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens |
| Q38058158 | Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults |
| Q38542900 | Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study. |
| Q85350626 | Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine |
| Q38059914 | Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults |
| Q53641472 | Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis. |
| Q87680192 | Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model |
| Q37668409 | Working together: interactions between vaccine antigens and adjuvants |
Search more.